Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Thyroid Related Upper Eyelid Retraction
NCT01272414Phase 4Withdrawn
- Sponsor
- University of Toronto
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in Graves' ophthalmopathy (TED), sponsored by University of Toronto. Planned start Jan 2011; status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
Graves' ophthalmopathy (TED)
Beyond the preview
Go deeper on NCT01272414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01272414.